Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

NCT01328535 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Melanoma
Stage IV Melanoma

Interventions

DRUG: temozolomide
OTHER: flow cytometry
OTHER: staining method
PROCEDURE: biopsy
OTHER: laboratory biomarker analysis

Sponsor

Mayo Clinic

Collaborators

[object Object]